This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David I. McLean, MD; Richard P. Gallagher, MA

Arch Dermatol. 1997;133(6):783-784.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THIS issue of the ARCHIVES, Zvulunov et al¹ report the absence of an apparent effect on nevus count of growth hormone administration in growth hormone-deficient children compared with control children. It is not illogical that preexisting nevi might be given a growth stimulus by exogenous growth hormones and indeed, in other studies,^2,3 exogenous growth hormone therapy has been suggested as being able to stimulate the growth rate of nevi, and increased DNA strand breaks have been noted in patients with Rothmund-Thomson syndrome treated with growth hormones.⁴ It is perhaps reasonable to assume that if the exogenous growth hormone is truly a replacement hormone, ie, the hormone is administered in amounts to mimic those found in individuals without growth hormone deficiency, there should be little effect on nevus growth in treated patients compared with healthy controls. Pharmacological doses may be another matter.

The study by Zvulunov et . . . [Full Text PDF of this Article]

Author Affiliations
Division of Dermatology University of British Columbia Vancouver Hospital and Health Sciences Centre 835 W 10th Ave Vancouver, British Columbia, Canada V5Z 4E8; Vancouver

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?